The government will pay $210 million for the doses, which Eli Lilly will ship by the end of March.
Category: Antibodies
People Who Have Had Covid Should Get Single Vaccine Dose, Studies Suggest
New studies show that one shot of a vaccine can greatly amplify antibody levels in those who have recovered from the coronavirus.
Childhood Colds Do Not Prevent Coronavirus Infection, Study Finds
New research casts doubt on the idea that prior infections with garden-variety coronaviruses might shield some people, particularly children, amid the pandemic.
F.D.A. Authorizes Another Antibody Treatment
Researchers hope Eli Lilly’s new combination therapy may be better able to fight virus variants than a similar treatment already in use.
How the Coronavirus Turns the Body Against Itself
Some patients struggling with Covid-19 develop antibodies against their own tissues, scientists have found.
Eli Lilly Claims Drug Prevents Coronavirus Infection in Nursing Homes
A monoclonal antibody protected residents and staff members in facilities where the virus had appeared.
Drug Prevents Coronavirus Infection in Nursing Homes, Maker Claims
A monoclonal antibody protected residents and staff members in facilities where the virus had appeared.
Emerging Coronavirus Variants May Pose Challenges to Vaccines
Laboratory studies of mutations circulating in South Africa suggest they may dodge some of the body’s immune responses.
Inside the B.1.1.7 Coronavirus Variant
What researchers have learned about the U.K. variant.
Blood Plasma Reduces Risk of Severe Covid-19 if Given Early
Thousands of people received convalescent plasma as an experimental treatment for Covid. A new study shows that it works — but only when given within a few days of the onset of illness.